SCHEMBL6967305

SCHEMBL6967305

O=C1CCCCC(Cc2nc(C(F)(F)F)nn2-c2ccccc2)N1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 1/20 0.36
OGFRL1 Q5TC84 1/20 0.36
CTSD P07339 2/20 0.35
CYP2C9 P11712 2/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
GRIA2 P42262 1/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
HTT P42858 1/20 0.32
KMT2A Q03164 2/20 0.32
MEN1 O00255 1/20 0.32
LMNA P02545 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C19 P33261 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
SIGMAR1 Q99720 1/20 0.32
SLC5A1 P13866 5/20 0.32
CES2 O00748 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6977098 0.87 CYP3A4 (0.31) CYP2C9CYP3A4CYP2D6GRIA2LMNA
SCHEMBL6977100 0.81 KDM4E (0.31) ALDH1A1HTTLMNACYP1A2SMN1; SMN2
SCHEMBL6976465 0.80 PTGS1 (0.41) CTSD
SCHEMBL6967526 0.74 MPO (0.38) CTSDALDH1A1
SCHEMBL6980192 0.73 PTGS1 (0.31) SMN1; SMN2
SCHEMBL6968580 0.73 CA1 (0.41) CTSDALDH1A1HPGDLMNASMN1; SMN2
SCHEMBL23459341 0.69 CTSD (0.58) CTSD
SCHEMBL6970123 0.69 CTSD (0.58) CTSD
SCHEMBL8181137 0.69 FFAR1 (0.34) CTSDCES2
SCHEMBL8175125 0.68 KDM4E (0.33) CTSDALDH1A1CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0821674-B1 CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS SEARLE & CO (US) 2003-08-06 EP disclosed
US-6043261-A TREATMENT OF INFLAMMATORY CONDITIONS AFFECTING THE JOINTS, FOR EXAMPLE ARTHRITIS, INFLAMMATORY BOWEL DISEASE, CARDIOVASCULAR ISCHEMIA, DIABETES, HYPERALGESIA, CEREBRAL ISCHEMIA, THROMBOTIC STROKE, GLOBAL ISCHEMIA, NERVOUS SYSTEM DISORDERS G. D. SEARLE & CO. (US) 2000-03-28 US disclosed
US-6011028-A Cyclic amidino agents useful as nitric oxide synthase inhibitors G.D. SEARLE & CO. (US) 2000-01-04 US disclosed
EP-0821674-A1 CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1998-02-04 EP disclosed
WO-1996033175-A1 CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1996-10-24 WO disclosed